Celgene Revenue and Competitors
Estimated Revenue & Valuation
- Celgene's total funding is $103.5M.
Employee Data
- Celgene has 2734 Employees.
- Celgene grew their employee count by -13% last year.
Celgene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Celgene?
Celgene Corporation, headquartered in Warren, New Jersey, is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
keywords:N/A
$103.5M
Total Funding
2734
Number of Employees
N/A
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Celgene's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Scientist, Analytical Development GMP | Reveal Email/Phone |
2 | Sr. Manager Engineering and Construction | Reveal Email/Phone |
3 | Senior Director, Predictive Science Engineering | Reveal Email/Phone |
4 | Associate Director - Research Strategy and Operations | Reveal Email/Phone |
5 | Sr. Administrative Assistant | Reveal Email/Phone |
6 | Technical Specialist,IMSC | Reveal Email/Phone |
7 | Analytical R&D | Reveal Email/Phone |
8 | Sr Financial System Analyst | Reveal Email/Phone |
9 | Sr. Strategic Planner, Global Investigational Material Supply Chain | Reveal Email/Phone |
10 | Director Clinical Operations | Reveal Email/Phone |
Celgene News
2022-04-20 - Thalassemia Market Size, Outlook And Forecast | Bluebird bio ...
Bluebird bio, Acceleron Pharma, Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma,...
2022-04-20 - Myeloproliferative Disorders Drugs Market Size, Outlook And ...
Celgene, Bristol-Myers Squibb, Gamida Cell, Incyte, Geron, Promedior, Johnson & Johnson. This comprehensive Myeloproliferative Disorders...
Other Companies in Summit
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $849.8M | 4228 | 2% | N/A |